Europe’s leading cancer conference may be swimming in antibody-drug conjugate (ADC) data, but AstraZeneca remains convinced that its in-house pipeline…

In recent years, the exploration of autism spectrum disorder (ASD) has gained significant focus in research, shedding light on the…

In the relentless battle against prostate cancer, a beacon of hope emerges from the ancient spice turmeric. A newly published…

Recent research has shed light on the intricate relationship between personality traits and eating disorders, revealing critical insights that could…

The prevalence of chronic kidney disease (CKD) has reached alarming levels worldwide, and this condition is particularly problematic in Saudi…

In a groundbreaking study, researchers have unveiled the profound impact of Medwakh smoking on salivary proteins and cytokine expression. This…

In a landmark advancement for the treatment of rare neuroendocrine tumors, researchers have reported groundbreaking results with the oral HIF-2α…

In the quest to find effective treatments for insomnia, particularly when accompanied by depressive symptoms, recent research has shed light…

In a landmark advancement for the treatment of metastatic estrogen-receptor-positive (ER-positive), HER-2-negative breast cancer, new clinical trial results reveal a…

Tubulis’ next-generation antibody-drug conjugate (ADC) has been tied to an overall response rate (ORR) of 59% as the German biotech…